Filter Results
:
(4,023)
Show Results For
-
All HBS Web
(8,222)
- People (21)
- News (2,550)
- Research (4,023)
- Events (18)
- Multimedia (276)
- Faculty Publications (3,287)
Show Results For
-
All HBS Web
(8,222)
- People (21)
- News (2,550)
- Research (4,023)
- Events (18)
- Multimedia (276)
- Faculty Publications (3,287)
Sort by
- December 2014
- Case
DaVita HealthCare Partners and the Denver Public Schools: Creating Connections
By: John J-H Kim and Christine S. An
In 2011, DaVita HealthCare Partners (DaVita)—a Fortune 500 healthcare services company specializing in kidney dialysis services—and the Denver Public Schools (DPS)—the largest school district in Colorado—forged a plan to incorporate greater intentional focus on culture...
View Details
Keywords:
Corporate-community Partnerships;
K-12;
School Districts;
DaVita;
Kent Thiry;
Tom Boasberg;
Denver Public Schools;
Wisdom Team;
DaVita Way;
Creating Connections;
Social Enterprise;
Community Impact;
Education Reform;
Public Schools;
Leadership Development;
Partners and Partnerships;
Social Entrepreneurship;
Education;
Business and Community Relations;
Culture;
Health Industry;
Health Industry;
Colorado
Kim, John J-H, and Christine S. An. "DaVita HealthCare Partners and the Denver Public Schools: Creating Connections." Harvard Business School Case 315-047, December 2014.
- April 1995 (Revised August 1995)
- Supplement
Empire Blue Cross and Blue Shield (D)
By: Regina E. Herzlinger and Ramona Hilgenkamp
Supplements the (A) case.
View Details
Herzlinger, Regina E., and Ramona Hilgenkamp. "Empire Blue Cross and Blue Shield (D)." Harvard Business School Supplement 195-219, April 1995. (Revised August 1995.)
- March 2010
- Teaching Note
Narayana Hrudayalaya Heart Hospital: Cardiac Care for the Poor (TN)
By: Tarun Khanna and V. Kasturi Rangan
Teaching Note for [505078].
View Details
- November 2006 (Revised March 2008)
- Case
The Harvard Stem Cell Institute
Describes a set of issues confronting the leaders of the Harvard Stem Cell Institute, an innovative cross-university effort to accelerate scientific discovery and translation in the domain of stem cells. Covers a wide range of topics, including understanding how...
View Details
Keywords:
Talent and Talent Management;
Higher Education;
Entrepreneurship;
Collaborative Innovation and Invention;
Intellectual Property;
Research and Development;
Genetics;
Health Industry;
Health Industry;
Massachusetts
Sahlman, William A. "The Harvard Stem Cell Institute." Harvard Business School Case 807-096, November 2006. (Revised March 2008.)
- September 2006 (Revised February 2007)
- Case
Timing of Option Grants at UnitedHealth Group (A)
Faced with press allegations that executives' stock options might have been backdated, the Board of UnitedHealth Group needs to determine whether its accounting for the options was proper, and if not, what the restatement amount should be and what...
View Details
Keywords:
Governing and Advisory Boards;
Ethics;
Stock Options;
Accounting;
Crisis Management;
Corporate Governance;
Health Industry;
Health Industry;
United States
Ferri, Fabrizio. "Timing of Option Grants at UnitedHealth Group (A)." Harvard Business School Case 107-028, September 2006. (Revised February 2007.)
- 2007
- Article
Pharmacovigilance and the Missing Denominator: The Changing Context of Pharmaceutical Risk Mitigation
By: Arthur A. Daemmrich
In the wake of Vioxx, Avandia, and other recent prominent cases of drugs found to cause side effects after marketing, the safety of pharmaceuticals has come to the forefront of American public policy. Press attention, congressional investigations, and legislative...
View Details
Keywords:
Brands and Branding;
Policy;
Risk Management;
Government Legislation;
Risk and Uncertainty;
Goals and Objectives;
Customers;
Health Industry;
Health Industry;
United States
Daemmrich, Arthur A. "Pharmacovigilance and the Missing Denominator: The Changing Context of Pharmaceutical Risk Mitigation." Pharmacy in History 49, no. 2 (2007): 61–75.
- February 1997 (Revised June 1999)
- Teaching Note
Massachusetts General Hospital: CABG Surgery (A) TN
Teaching Note for (9-696-015).
View Details
- Article
Invisible Monuments and the Costs of Pharmaceutical Regulation: Twenty-Five Years of Drug Lag Debate
By: Arthur A. Daemmrich
Daemmrich, Arthur A. "Invisible Monuments and the Costs of Pharmaceutical Regulation: Twenty-Five Years of Drug Lag Debate." Pharmacy in History 45, no. 1 (2003): 3–17.
- January 2006
- Article
Hospital Integration and Vertical Consolidation: An Analysis of Acquisitions in New York State
Huckman, Robert S. "Hospital Integration and Vertical Consolidation: An Analysis of Acquisitions in New York State." Journal of Health Economics 25, no. 1 (January 2006): 58–80.
- 22 Mar 2016
- First Look
March 22, 2016
note explains Cuba's past and current agriculture policies and provides insights into its future potential as relations with the U.S. normalize. Purchase this case: https://cb.hbsp.harvard.edu/cbmp/product/516067-PDF-ENG Harvard Business School Case 916-044 Evive View Details
Keywords:
Sean Silverthorne
- 05 Feb 2009
- Research & Ideas
In Praise of Marketing
messages to those who are not interested in their products or services. It is now possible for chief marketing officers to calculate return on marketing investment and to report regularly to the corporate board progress against three or four brand and consumer View Details
- 29 Oct 2007
- HBS Case
Marketing Maria: Managing the Athlete Endorsement
brand and ensuring his or her success? A: The agent plays a critical role. Eisenbud is the liaison between Sharapova, the companies whose products she endorses, and any other interested parties. It's up to Eisenbud and his team to ensure the View Details
- 21 Jun 2010
- Research & Ideas
Strategy and Execution for Emerging Markets
reasonable prices are in demand. One example: In health care, GE is producing a computerized tomography (CT) scan machine that is functional without a lot of bells and whistles. It was designed originally for the Chinese market where...
View Details
Keywords:
by Martha Lagace
- 17 Oct 2017
- First Look
First Look at New Research and Ideas, October 17, 2017
patient satisfaction, and problems with patient safety. Nearly all U.S. health care organizations have used similar evidence to justify their investments in safety and quality. Herein, we provide conservative formulas based on readily...
View Details
Keywords:
Sean Silverthorne
- 14 May 2013
- First Look
First Look: May 14
to create an alliance for clean cookstoves, a significant environmental and public health issue in developing countries. This case examines the change process within the State Department and across the federal government as well as the...
View Details
Keywords:
Sean Silverthorne
- 20 Sep 2011
- First Look
First Look: September 20
Hospital: Cardiac Care for the Poor (B) Tarun Khanna and Tanya BijlaniHarvard Business School Supplement 712-402 Narayana Hrudayalaya (NH) has expanded into a multi-specialty health city in Bangalore and has grown to twelve locations...
View Details
Keywords:
Sean Silverthorne
- 18 Aug 2011
- Lessons from the Classroom
Business Plan Contest: 15 Years of Building Better Entrepreneurs
the power to impact the health of millions rallied the team, recalls Jon Puz (MBA '08), a director of account management at the health-care consultancy Carol Corp. (Puz continues to serve DFA in an advisory role; DFA's original team also...
View Details
- April 2021 (Revised April 2021)
- Case
Project Restart: Deciding the Future of English Football
By: Nour Kteily and Deepak Malhotra
In March 2020, the English Premier League football (soccer) season was suspended partway through due to the COVID-19 pandemic. Two months later the season remained in limbo, with a looming deadline to decide whether to attempt to complete the season or curtail it—and...
View Details
Keywords:
COVID-19 Pandemic;
Sports;
Health Pandemics;
Decision Making;
Fairness;
Values and Beliefs;
Business and Stakeholder Relations;
Motivation and Incentives;
Outcome or Result;
Perception;
Negotiation;
Sports Industry;
United Kingdom
Kteily, Nour, and Deepak Malhotra. "Project Restart: Deciding the Future of English Football." Harvard Business School Case 921-050, April 2021. (Revised April 2021.)
- January 2020
- Case
Celata Bioinnovations
By: John R. Wells and Benjamin Weinstock
In December 2019, Jon Hu (HBS ‘19) and Dr. Samantha Dale Strasser, co-founders of Celata Bioinnovations, were raising $1 million to launch their company. They had founded Celata less than six months earlier with the aim of redefining the drug discovery process....
View Details
Keywords:
Drug Development;
Drug Discovery;
Drug Trials;
Pharmaceutical Companies;
Pharmaceutical Company;
Pharmaceuticals;
Therapeutics;
Biologics;
Biotech;
Biotechnology;
Biopharmacy Company;
Biochemistry;
Technology Commercialization;
Technology Companies;
Drug Testing;
Startup;
Start-up;
Startups;
Start-ups;
Startup Financing;
Strategic Decision Making;
Strategic Decisions;
Strategic Evolution;
FDA;
Food And Drug Administration;
Clinical Trials;
Disease Management;
Market Attractiveness;
Market Entry;
Market Opportunities;
Health Disorders;
Technological Innovation;
Information Technology;
Commercialization;
Business Startups;
Finance;
Decision Making;
Strategy;
Market Entry and Exit;
Opportunities;
Pharmaceutical Industry;
Biotechnology Industry
Wells, John R., and Benjamin Weinstock. "Celata Bioinnovations." Harvard Business School Case 720-427, January 2020.
- 26 Aug 2014
- First Look
First Look: August 26
(ToM) allows children to achieve success in the social world by understanding others' minds. A study with 3-12 year olds, however, demonstrates that gains in ToM are linked to decreases in children's desire to engage in performative behaviors associated with View Details
Keywords:
Sean Silverthorne